191 related articles for article (PubMed ID: 26124367)
1. Characteristics and Treatment Strategies for Small Bowel Adenocarcinoma in Advanced-stage Cases.
Nakanoko T; Koga T; Taketani K; Hirayama Y; Yoshiya S; Minagawa R; Kai M; Kajiyama K; Maehara Y
Anticancer Res; 2015 Jul; 35(7):4135-8. PubMed ID: 26124367
[TBL] [Abstract][Full Text] [Related]
2. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the TNM-classification for small bowel cancer.
Contant CM; Damhuis RA; van Geel AN; van Eijck CH; Wiggers T
Hepatogastroenterology; 1997; 44(14):430-4. PubMed ID: 9164514
[TBL] [Abstract][Full Text] [Related]
4. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
[TBL] [Abstract][Full Text] [Related]
6. Prognostic clinicopathological factors after curative resection of small bowel adenocarcinoma.
Inoue Y; Hayashi M; Satou N; Miyamoto Y; Hirokawa F; Asakuma M; Shimizu T; Kayano H; Yamamoto M; Yamana H; Okuda J; Egashira Y; Tanigawa N
J Gastrointest Cancer; 2012 Jun; 43(2):272-8. PubMed ID: 21607548
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of and chemotherapy for cancer of the small intestine.
Higashi D; Ishibashi Y; Tamura T; Nii K; Egawa Y; Koga M; Tomiyasu T; Harimura T; Tanaka R; Futatsuki R; Noda S; Futami K; Maekawa T; Takaki Y; Hirai F; Matsui T
Anticancer Res; 2010 Aug; 30(8):3193-7. PubMed ID: 20871040
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.
Wu TJ; Yeh CN; Chao TC; Jan YY; Chen MF
World J Surg; 2006 Mar; 30(3):391-8; discussion 399. PubMed ID: 16479330
[TBL] [Abstract][Full Text] [Related]
11. New aspects of prognostic factors in adenocarcinomas of the small bowel.
Brücher BL; Stein HJ; Roder JD; Busch R; Fink U; Werner M; Siewert JR
Hepatogastroenterology; 2001; 48(39):727-32. PubMed ID: 11462914
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy in advanced small bowel adenocarcinoma.
Locher C; Malka D; Boige V; Lebray P; Elias D; Lasser P; Ducreux M
Oncology; 2005; 69(4):290-4. PubMed ID: 16282708
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
[TBL] [Abstract][Full Text] [Related]
16. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
[TBL] [Abstract][Full Text] [Related]
17. [A case report of primary adenocarcinoma of small intestine successfully treated with FOLFOX].
Sugae T; Yaguchi T; Kajikawa M; Nakayama S; Takase T; Inokawa Y; Tsushima Y; Watanabe T; Harada A
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1969-71. PubMed ID: 19011354
[TBL] [Abstract][Full Text] [Related]
18. Management of small bowel adenocarcinoma.
Kummar S; Ciesielski TE; Fogarasi MC
Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
